MetLife Investment Advisors LLC Takes Position in MaxLinear (MXL)

MetLife Investment Advisors LLC bought a new stake in shares of MaxLinear (NYSE:MXL) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 26,699 shares of the semiconductor company’s stock, valued at approximately $705,000.

A number of other institutional investors have also recently bought and sold shares of the business. Macquarie Group Ltd. boosted its stake in MaxLinear by 4.8% during the 4th quarter. Macquarie Group Ltd. now owns 3,380,029 shares of the semiconductor company’s stock valued at $89,300,000 after purchasing an additional 154,980 shares during the period. Meadow Creek Investment Management LLC acquired a new position in MaxLinear during the 4th quarter valued at about $216,000. TIAA CREF Investment Management LLC boosted its stake in MaxLinear by 12.0% during the 4th quarter. TIAA CREF Investment Management LLC now owns 179,028 shares of the semiconductor company’s stock valued at $4,730,000 after purchasing an additional 19,168 shares during the period. Paloma Partners Management Co boosted its stake in MaxLinear by 461.7% during the 4th quarter. Paloma Partners Management Co now owns 48,202 shares of the semiconductor company’s stock valued at $1,273,000 after purchasing an additional 39,621 shares during the period. Finally, Raymond James & Associates boosted its stake in MaxLinear by 197.6% during the 4th quarter. Raymond James & Associates now owns 129,870 shares of the semiconductor company’s stock valued at $3,431,000 after purchasing an additional 86,237 shares during the period. 89.71% of the stock is owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

Shares of NYSE:MXL opened at $23.17 on Monday. The company has a market capitalization of $1,569.96, a PE ratio of 19.64 and a beta of 0.54. MaxLinear has a twelve month low of $20.38 and a twelve month high of $32.47. The company has a quick ratio of 1.94, a current ratio of 2.64 and a debt-to-equity ratio of 0.90.

MaxLinear (NYSE:MXL) last issued its quarterly earnings results on Tuesday, February 13th. The semiconductor company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. The company had revenue of $113.72 million during the quarter, compared to analyst estimates of $114.01 million. MaxLinear had a negative net margin of 2.19% and a positive return on equity of 20.70%. equities analysts forecast that MaxLinear will post 1.26 earnings per share for the current year.

In other news, insider Curtis Ling sold 22,321 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $22.90, for a total value of $511,150.90. Following the completion of the sale, the insider now directly owns 912,117 shares of the company’s stock, valued at approximately $20,887,479.30. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Michael J. Lachance sold 25,000 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $23.63, for a total transaction of $590,750.00. Following the completion of the sale, the vice president now directly owns 71,757 shares of the company’s stock, valued at $1,695,617.91. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 72,321 shares of company stock valued at $1,678,901. Company insiders own 11.92% of the company’s stock.

A number of research analysts have issued reports on the stock. Zacks Investment Research lowered shares of MaxLinear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, January 10th. Needham & Company LLC reduced their target price on shares of MaxLinear from $32.00 to $30.00 and set a “buy” rating for the company in a research note on Wednesday, February 14th. Finally, Roth Capital reaffirmed a “buy” rating and issued a $33.00 price target on shares of MaxLinear in a research note on Friday, December 29th. Two equities research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $31.20.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/04/16/metlife-investment-advisors-llc-takes-position-in-maxlinear-mxl.html.

MaxLinear Profile

MaxLinear, Inc is a provider of radio frequency (RF) and mixed-signal integrated circuits for cable and satellite broadband communications and the connected home, and wired and wireless infrastructure markets. The Company’s RF receiver products capture and process digital and analog broadband signals to be decoded for various applications.

Want to see what other hedge funds are holding MXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MaxLinear (NYSE:MXL).

Institutional Ownership by Quarter for MaxLinear (NYSE:MXL)

Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply